Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma. [electronic resource]
Producer: 20060811Description: 825-9 p. digitalISSN:- 0268-3369
- Aged
- Angiogenesis Inhibitors -- therapeutic use
- Combined Modality Therapy
- Disease Progression
- Female
- Humans
- Male
- Middle Aged
- Multiple Myeloma -- blood supply
- Neoplasm Staging
- Stem Cell Transplantation -- adverse effects
- Survival Analysis
- Survivors
- Thalidomide -- therapeutic use
- Time Factors
- Transplantation, Autologous
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.